effects of semaglutide on kidneys canagliflozin significantly reduces the risk of kidney failure - Semaglutideandkidneys lowers fat tissue around the kidneys The Multifaceted Effects of Semaglutide on Kidney Health

Effects of semaglutide onchronic kidney disease in patients with type 2 diabetes pdf Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has emerged as a significant therapeutic agent, particularly for individuals with type 2 diabetes and obesity. While its primary indications focus on glycemic control and weight management, a growing body of evidence highlights its profound and often protective effects of semaglutide on kidneysThey also found that thekidneys were better maintained with semaglutide. There was a slower yearly decline eGFR levels (1.16 ml/min/1.73 m2 lower in the .... This article delves into the intricate ways Semaglutide influences kidney function, examining both its established benefits and potential considerations, drawing upon recent research and clinical trial data.

For individuals with type 2 diabetes and chronic kidney disease (CKD), the effects of semaglutide on chronic kidney disease in patients with type 2 diabetes are of paramount importance. Patients in this demographic are at a notably high risk for kidney failure, cardiovascular events, and mortality. Semaglutide has demonstrated a compelling ability to mitigate these risks. Landmark studies, such as the FLOW trial, have specifically investigated these outcomes.Semaglutide and kidney function: direct kidney protection ... The FLOW trial results indicated that semaglutide significantly reduced the risk of clinically important kidney outcomes and death from cardiovascular causesAssessing the Renal Outcomes of Semaglutide in Diabetic .... Specifically, semaglutide (1 mg subcutaneously once weekly) decreased the primary kidney outcome by 24% compared to placebo, a finding echoed in other analyses showing semaglutide may lower the risk of kidney disease-related events by 24% in adults with CKD and Type 2 diabetesGlucagon-like Peptide-1 Receptor Agonists: New Evidence ....

One of the key mechanisms by which Semaglutide exerts its renal benefits involves its direct impact on kidney pathology.Mechanistic effects of semaglutide reduce albuminuria ... Research suggests that semaglutide reduced kidney fat, improved glomerular hemodynamic effects, and ameliorated endothelial injury. Furthermore, studies have indicated that semaglutide reduces glomerulosclerosis and renal fibrosis, conditions that contribute to progressive kidney damage. These mechanistic effects are crucial in understanding how GLP-1RA treatment exerts multiple potentially beneficial effects on the kidneys.

The impact on renal fat mass, along with glomerular hemodynamics, inflammation and cortical fibrosis, points to a multi-pronged approach to preserving kidney health. The drug's ability to lower fat tissue around the kidneys is also a significant factor. Moreover, semaglutide has shown promise in preventing the development or progression of macroalbuminuria, a key indicator of kidney damage. This ability to prevent the onset of macroalbuminuria is highlighted as a pivotal factor in reducing the likelihood of kidney-related complications.

While the overall outlook for semaglutide's renal effects is positive, it's important to acknowledge the complexity.作者：MW Taal·2025·被引用次数：13—Thus,GLP-1RA treatment exerts multiple potentially beneficial effects on the kidneys(Fig 1), providing a rationale for dedicated trials with ... Some studies have reported initial reductions in estimated glomerular filtration rate (eGFR) with semaglutide, which then plateaued.Effects of Semaglutide on Chronic Kidney Disease in Patients ... However, other research, particularly concerning oral semaglutide, showed that it improved eGFR, with no significant differences observed in adverse events. The impact of semaglutide on eGFR was variable, with some studies reporting decreases and others showing improvements or no significant changes.作者：JFE Mann·2020·被引用次数：167—Across the SUSTAIN 1–7 trials,semaglutide was associated with initial reductions in eGFR that plateaued, and marked reductions in UACR. This variability underscores the need for ongoing monitoring and personalized treatment approaches.

It's also crucial to address the rare instances of acute kidney injury associated with semaglutide.Cardio-kidney-metabolic protective effects of semaglutide ... While generally considered safe for renal function, there have been case reports where a rapid decline in kidney function was temporally associated with semaglutide administration. In some of these instances, substantial weight loss, a known effect of semaglutide, may have contributed to the decline in kidney function. Therefore, vigilance and early identification of potential adverse effects remain important. However, the overwhelming evidence points towards a net benefit, with semaglutide being considered a valuable tool to help slow progression of kidney disease and reduce the risk of death from kidney-related causes.

In conclusion, the evidence overwhelmingly supports the beneficial effects of semaglutide on kidneys, particularly in the context of type 2 diabetes and CKD. Its ability to reduce the risk of major renal events, improve kidney fat, modulate glomerular hemodynamics, and combat fibrosis positions it as a significant advancement in managing kidney health. While the possibility of initial eGFR fluctuations and rare instances of acute kidney injury warrant careful consideration, the broad protective capabilities of Semaglutide make it a vital therapeutic option for a wide range of patientsGlucagon-like Peptide-1 Receptor Agonists: New Evidence .... The ongoing research, including detailed analyses of trials like the FLOW trial, continues to illuminate the profound and positive role Semaglutide plays in preserving renal function.